SGF, which contains exosomes, has been shown to significantly improve pneumonia symptoms and has a track record of being effective for various post-COVID-19 sequelae symptoms. If you are experiencing post-COVID-19 sequelae, especially after a new coronavirus infection, please do not hesitate to consult with us.

Expected Mechanism of Action

There is a possibility that the cytokines present in SGF preemptively bind to ACE2, the receptor for the new coronavirus COVID-19, thereby inhibiting infection.

Confirmed Cases

Improvement in physical and psychological symptoms by intravenous administration of SGF for the treatment of COVID-19 patients, as well as improvement in pneumonia symptoms through inhalation.

Treatment Options Offered

SGF Intravenous Drip – 5cc for 55,000 JPY (Including Consumption Tax)

Inhalation Set – 99,000 JPY (Including Consumption Tax)

SGF 5cc
Basic Inhaler
Oxygen Saturation Monitor (Saturator)
(Additional SGF 5cc available for 55,000 JPY, including consumption tax)

＊Please note that our clinic operates on a fee-for-service basis and is not covered by public medical insurance.